This is filed to report post procedure,a single leaflet device attachment and recurrent mr occurred.It was reported that this was a mitraclip procedure on 12/30/2020 to treat tricuspid regurgitation (tr) with grade 4+.One clip was implanted on the anterior and septal leaflets, reducing tr to 2.Imaging was poor during the procedure.The next day, the transthoracic echocardiography showed tr returned to a grade 4.A single leaflet device attachment was noted.There was no tissue damage noted.There was no additional treatment performed or planned.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents reported from this lot.A cause for the reported single leaflet device attachment (slda) could not be determined.The reported recurrent tricuspid regurgitation (tr) appears to have been a result of the slda.A cause for the reported poor imaging could not be determined.It should be noted that per the mitraclip system instructions for use states: ¿the mitraclip¿ g4 system is indicated for the percutaneous reduction of significant symptomatic mitral regurgitation (mr)." based on the available information, the reported off-label use was due to the device being used on a tricuspid valve.However, it cannot be confirmed in this case if the off-label use contributed to the reported slda.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|